Abstract: Objective: To analyze the clinical features and ophthalmoplegic characteristics of ocular myasthenia gravis (OMG) in adult patients. Methods: A retrospective case series study of the medical records of 40 adult patients diagnosed with OMG at the First Affiliated Hospital of Jinan University from June 2016 to October 2019 was performed to analyze the clinical features of OMG. The descriptive statistics included the duration of symptoms, gender distribution, ocular symptoms, diplopia features, ophthalmoplegic characteristics and the results of diagnostic tests. Results: Of the 40 adult OMG patients, 50% of the cases (20) were men. The median course of the disease among all patients was 6 months (range: 1 month to 10 years). At the first visit, 27 patients (68%) showed diplopia only, 9 patients (22%) showed ptosis only, 4 patients (10%) showed diplopia with ptosis. Among the patients with diplopia (n=31), 20 cases (64%) showed horizontal diplopia and 11 cases (35%) showed vertical diplopia. Multiple binocular extraocular muscles were affected in all diplopia patients. The most paralytic extraocular muscle was the lateral rectus (16 cases, 52%), and in descending order, the superior rectus (6 cases, 19%), medial rectus (4 cases, 13%), inferior rectus (3 cases, 10%), superior oblique (1 case, 3%), and inferior oblique (1 case, 3%). A neostigmine test was positive in 32 of 40 patients (80%), acetycholine receptor antibody assay was positive in 4 of 40 patients (10%), abnormal electromyography results were found in 2 of 40 patients (5%), thymus CT showed abnormal findings in 5 of 40 patients (13%), and 19 cases (48%) combined the thymus with thyroid disorders. Conclusions: Horizontal diplopia was the initial symptom in most adult OMG patients and the lateral rectus was the most susceptible muscle.
Huang X, Li Y, Feng H, et al. Clinical Characteristics of Juvenile Myasthenia Gravis in Southern China. Front Neurol, 2018, 9: 77. DOI: 10.3389/fneur.2018.00077.
Liu R, Xu H, Wang G, et al. Extraocular muscle characteristics related to myasthenia gravis susceptibility. PLoS one, 2013, 8(2): e55611. DOI: 10.1371/journal.pone.0055611.
Peragallo JH, Bitrian E, Kupersmith MJ, et al. Relationship between age, gender, and race in patients presenting with myasthenia gravis with only ocular manifestations. J Neuroophthalmol, 2016, 36(1): 29-32. DOI: 10.1097/ WNO.0000000000000276.
Almog Y, Ben-David M, Nemet AY. Inferior oblique muscle paresis as a sign of myasthenia gravis. J Clin Neurosci, 2016, 25: 50-53. DOI: 10.1016/j.jocn.2015.08.026.
[11]
Wirth MA, Valko Y, Rosengren SM, et al. Repetitive ocular vestibular evoked myogenic potential stimulation for the diagnosis of myasthenia gravis: Optimization of stimulation parameters. Clin Neurophysiol, 2019, 130(7): 1125-1134. DOI: 10.1016/j.clinph.2019.03.033.
[12]
Cleary M, Williams GJ, Metcalfe RA. The pattern of extra-ocular muscle involvement in ocular myasthenia. Strabismus, 2008, 16(1): 11-18. DOI: 10.1080/15569520701830992.
[13]
Hsu SY, Tsai RK, Wang HZ, et al. A comparative study of ocular and generalized myasthenia gravis. Kaohsiung J Med Sci, 2002, 18(2): 62-69. DOI: 10.6452/KJMS.200202.0062.
[14]
Batocchi AP, Evoli A, Majolini L, et al. Ocular palsies in the absence of other neurological or ocular symptoms: analysis of 105 cases. J Neurol, 1997, 244(10): 639-645. DOI: 10.1007/ s004150050160.
[15]
Nair AG, Patil-Chhablani P, Venkatramani DV, et al. Ocular myasthenia gravis: A review. Indian J Ophthalmol, 2014, 62(10): 985-991. DOI: 10.4103/0301-4738.145987.
[16]
Patil SA, Bokoliya SC, Nagappa M, et al. Diagnosis of myasthenia gravis: Comparison of anti-nicotinic acetyl choline receptor antibodies, repetitive nerve stimulation and Neostigmine tests at a tertiary neuro care centre in India, a ten year study. J Neuroimmunol, 2016, 292: 81-84. DOI: 10.1016/ j.jneuroim.2016.01.006.
[17]
Sieb JP. Myasthenia gravis: An update for the clinician. Clin Exp Immunol, 2014, 175(3): 408-418. DOI: 10.1111/cei.12217.
Dagi LR, Zoumalan CI, Konrad H, et al. Correlation between extraocular muscle size and motility restriction in thyroid eye disease. Ophthal Plast Reconstr Surg, 2011, 27(2): 102-110. DOI: 10.1097/IOP.0b013e3181e9a063.